A proud member of BIO

The North Carolina Biosciences Organization

Neurotechnology Industry Organization

Targacept is the leading CNS-focused biopharmaceutical company with an extensive portfolio of candidates for first-in-class therapies


Targacept, Inc. is a biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics (TM), a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system. Our NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.

We currently have a robust clinical-stage product pipeline and multiple preclinical product candidates. Our most advanced product candidates are in development for major depressive disorder, attention deficit/hyperactivity disorder, Alzheimer’s disease  and cognitive dysfunction in schizophrenia.

Targacept is located in Winston-Salem, North Carolina.


Targacept Named 10th Overall in Best Places to Work Survey
On May 26, 2009, The Scientist, magazine of the life sciences, announced the winners of its 7th annual "Best Places to Work in Industry" survey and Targacept was among the award winners...more.....

 

Candidates in Pipeline
Targacept has several product candidates in clinical development.
View our pipeline to learn more.

 

2010 North Carolina Science Festival
Targacept is proud to support the 2010 North Carolina Science Festival, Sept. 11 – 26, 2010. The Festival is a multi-day celebration that will showcase science throughout the state, featuring hands-on activities, lab tours, science talks, exhibits, performances and more. learn more.
Targeting NNRs
Watch the animation to find out how our drugs work in the nervous system.
 
   
   
   
Latest News
September 07, 2010
August 04, 2010
August 03, 2010
June 23, 2010
May 19, 2010
May 03, 2010
January 11, 2010
December 03, 2009
©2010 Targacept, Inc. Terms of Use Directions Contact Site Map  Go